camptothecin has been researched along with Carcinoma, Transitional Cell in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.14) | 18.7374 |
| 1990's | 3 (21.43) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 2 (14.29) | 24.3611 |
| 2020's | 5 (35.71) | 2.80 |
| Authors | Studies |
|---|---|
| Boudreau, J; Bulin, J; Hanna, KS; Larson, S; Nguyen, J; Rolf, M | 1 |
| Agarwal, N; Mathew Thomas, V; Swami, U; Tripathi, N | 1 |
| Al-Ahmadie, H; Almassi, N; Alvim, R; Audenet, F; Bagrodia, A; Chen, Z; Clinton, TN; Cocco, E; Coleman, JA; Dason, S; Dong, Y; Elzein, A; Gao, J; Gao, SP; Gordon, B; Hakimi, AA; Hanrahan, AJ; Hsieh, JJ; Hu, W; Hughes, C; Iyer, G; Jebiwott, S; Kim, K; Mohan, V; Murray, K; Nagar, K; Ostrovnaya, I; Penson, A; Pietzak, EJ; Rosenberg, JE; Sagi, I; Santin, AD; Scaltriti, M; Solit, DB; Vargas, HA; Watson, PA; Wong, N | 1 |
| Gross-Goupil, M; Thibault, C | 1 |
| Agarwal, N; Grivas, P; Pal, SK; Swami, U | 1 |
| Faltas, B; Goldenberg, DM; Govindan, SV; Hajdenberg, J; Hodes, G; Nanus, DM; Ocean, AJ; Sharkey, RM; Tagawa, ST; Wilhelm, F | 1 |
| Jin, HS; Wang, XW; Yan, ZL; Ye, G; Yi, SH; Zhang, YN | 1 |
| Bhattacharyya, M; Mutsvangwa, K; Oliver, T; Powles, T; Shamash, J; Wilson, P | 1 |
| Cao, Y; Chen, F; Payne, R; See, WA; Zhang, G | 1 |
| Agarwal, M; Beer, TM; Crawford, ED; Goldman, B; Nichols, CR; Petrylak, DP; Ryan, CW | 1 |
| Asakuno, K; Kohno, K; Kotoh, S; Kumazawa, J; Kuwano, M; Naito, S; Yokomizo, A | 1 |
| Abi-Aad, AS | 1 |
| Shimizu, Y | 1 |
| Feng, T; Gu, FL; Shi, T; Wu, JP | 1 |
5 review(s) available for camptothecin and Carcinoma, Transitional Cell
| Article | Year |
|---|---|
The role of enfortumab vedotin and sacituzumab govitecan in treatment of advanced bladder cancer.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Camptothecin; Carcinoma, Transitional Cell; Humans; Immunoconjugates; Urinary Bladder Neoplasms | 2022 |
Current and emerging role of sacituzumab govitecan in the management of urothelial carcinoma.
Topics: Antibodies, Monoclonal, Humanized; Camptothecin; Carcinoma, Transitional Cell; Clinical Trials, Phase II as Topic; Diarrhea; Humans; Immunoconjugates; Irinotecan; Neutropenia; Urinary Bladder Neoplasms | 2022 |
[Innovations in systemic treatment of urothelial carcinoma].
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Camptothecin; Carcinoma, Transitional Cell; Humans; Immunoconjugates; Immunotherapy; Receptors, Fibroblast Growth Factor; Therapies, Investigational; Urinary Bladder Neoplasms | 2020 |
Chemotherapy for advanced bladder carcinoma: new molecules and regimens.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Doxorubicin; Folic Acid Antagonists; Gallium; Gemcitabine; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Methotrexate; Paclitaxel; Urinary Bladder Neoplasms; Vinblastine | 1996 |
Individualized chemotherapeutic regimen for each histological subtype of ovarian carcinoma.
Topics: Adenocarcinoma, Mucinous; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma; Carcinoma, Endometrioid; Carcinoma, Transitional Cell; Cisplatin; Cystadenocarcinoma, Serous; Drug Resistance, Neoplasm; Female; Humans; Irinotecan; Mitomycin; Ovarian Neoplasms | 1997 |
3 trial(s) available for camptothecin and Carcinoma, Transitional Cell
| Article | Year |
|---|---|
Sacituzumab Govitecan, a Novel Antibody--Drug Conjugate, in Patients With Metastatic Platinum-Resistant Urothelial Carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Phytogenic; Camptothecin; Carcinoma, Transitional Cell; Disease-Free Survival; Drug Resistance, Neoplasm; Humans; Immunoconjugates; Lymphatic Metastasis; Male; Treatment Outcome; Urinary Bladder Neoplasms | 2016 |
A phase II study of mitomycin, fluorouracil, folinic acid, and irinotecan (MFI) for the treatment of transitional cell carcinoma of the bladder.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Camptothecin; Carcinoma, Transitional Cell; Cisplatin; Female; Fluorouracil; Humans; Irinotecan; Male; Middle Aged; Mitomycin; Time Factors; Treatment Outcome; Urinary Bladder Neoplasms; Urologic Neoplasms | 2013 |
Southwest Oncology Group phase II study of irinotecan in patients with advanced transitional cell carcinoma of the urothelium that progressed after platinum-based chemotherapy.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Disease Progression; Female; Gemcitabine; Humans; Irinotecan; Male; Middle Aged; Prospective Studies; Survival Rate; Topoisomerase I Inhibitors; Treatment Outcome; Urologic Neoplasms | 2008 |
6 other study(ies) available for camptothecin and Carcinoma, Transitional Cell
| Article | Year |
|---|---|
Modeling biological and genetic diversity in upper tract urothelial carcinoma with patient derived xenografts.
Topics: Aged; Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Biopsy; Camptothecin; Carcinoma, Transitional Cell; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genetic Variation; High-Throughput Nucleotide Sequencing; Humans; Immunoconjugates; Interleukin Receptor Common gamma Subunit; Male; Mice; Mice, Inbred NOD; Mice, SCID; Middle Aged; Mutation; Neoplasm Metastasis; Neoplasm Transplantation; Phenotype; Precision Medicine; Prospective Studies; Quinolines; Retrospective Studies; Sequence Analysis, RNA; Trastuzumab; Urinary Bladder Neoplasms; Urothelium | 2020 |
Utilization of systemic therapy for treatment of advanced urothelial carcinoma: Lessons from real world experience.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Camptothecin; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Disease-Free Survival; Drug Administration Schedule; Evidence-Based Medicine; Humans; Immunoconjugates; Medical Oncology; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Practice Patterns, Physicians'; Randomized Controlled Trials as Topic; Urinary Bladder Neoplasms | 2021 |
[Prophylactic effect of inductive intravesical instillation of Bacillus Calmette-Guerin on postoperative recurrence of bladder cancer].
Topics: Adjuvants, Immunologic; Administration, Intravesical; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; BCG Vaccine; Camptothecin; Carcinoma, Transitional Cell; Cystectomy; Female; Fever; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Urinary Bladder Neoplasms | 2008 |
Bacillus Calmette-Guerin inhibits apoptosis in human urothelial carcinoma cell lines in response to cytotoxic injury.
Topics: Adjuvants, Immunologic; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; BCG Vaccine; Camptothecin; Carcinoma, Transitional Cell; Cell Line, Tumor; Cell Proliferation; Cross-Linking Reagents; DNA Fragmentation; DNA, Neoplasm; Humans; Mitomycin; Urinary Bladder Neoplasms | 2007 |
Increased expression of DNA topoisomerase I gene and collateral sensitivity to camptothecin in human cisplatin-resistant bladder cancer cells.
Topics: Blotting, Northern; Camptothecin; Carcinoma, Transitional Cell; Cell Cycle; Cell Division; Cisplatin; DNA Topoisomerases, Type I; Drug Resistance; Drug Screening Assays, Antitumor; Gene Expression; Glutathione; Glutathione Transferase; Humans; Immunoblotting; Intracellular Fluid; RNA, Messenger; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1994 |
Factors influencing the absorption of antineoplastic agents in intravesical instillation treatment of bladder tumors. An experimental and clinical study.
Topics: Absorption; Administration, Intravesical; Adult; Aged; Animals; Camptothecin; Carcinoma, Transitional Cell; Female; Humans; Male; Middle Aged; Rabbits; Thiotepa; Urinary Bladder Neoplasms | 1987 |